Lapatinib: Clinical benefit in patients with HER2-positive advanced breast cancer

Additional Metadata
Keywords	Advanced breast cancer, Capecitabine, Her2, Lapatinib
Persistent URL	hdl.handle.net/1765/89900
Journal	The Netherlands Journal of Medicine
Organisation	Department of Bioinformatics
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Kroep, J., Linn, S., Boven, E., Bloemendal, H., Baas, J., Mandjes, I., Van Den Bosch, J., Smit, W., de Graaf, H., Schröder, C., Vermeulen, G. J., Hop, W.& Nortier, J. W. R. (2010). Lapatinib: Clinical benefit in patients with HER2-positive advanced breast cancer. The Netherlands Journal of Medicine, 68(9), 371–376.http://hdl.handle.net/1765/89900

Publication